Delivery Order SPE2DE21D0017-SPE2D625F5A1Y
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $4,800.00 on August 20, 2025, for COVID-19 test kits under contract 4569160719. This fixed-price contract with economic price adjustment has an ultimate completion date of August 29, 2025, and will be performed in Lockhart, Florida. The award was issued by the Defense Logistics Agency Medical Supply Chain without a set-aside designation, indicating open competition among...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 18, 2025, for COVID-19 test kits to support the Defense Logistics Agency Medical Supply Chain. The contract, designated as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of September 29, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- This is a federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of COVID-19 test kits with a ceiling value of $1,800.00 and a completion date of July 18, 2025. The contract type is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing structure. The contract does not have a set-aside designation. Abbott Rapid DX North America LLC is the...
- This federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, provides $4,440.00 for the delivery of COVID-19 test kits. The award was made by the Defense Logistics Agency Troop Support Medical, a unit of the U.S. Department of Defense, under a Delivery Order contract with a fixed price and economic price adjustment terms. The contract has an ultimate completion date of September 18, 2024. It is not designated as a set-aside contract. Abbott Rapid DX...
- The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $1.776 million fixed-price delivery order with economic price adjustment for COVID-19 test kits. Performance will take place in Lockhart, Florida over a one-week period concluding in mid-July 2023. The contract was awarded under an unspecified government-wide acquisition contract vehicle to supply diagnostic test materials in support of the Department of...
- The federal contract award is for the delivery of COVID-19 test kits to the Defense Logistics Agency Troop Support Medical unit. The prime contractor is Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories that specializes in medical diagnostic equipment and supplies. This is a fixed-price delivery order contract with economic price adjustments, valued at $222,000.00, with a completion date of October 9, 2024. The contract does not have a set-aside designation. Abbott Rapid...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $2,664.00, is for the delivery of COVID-19 test kits. The contract is a fixed-price with economic price adjustment delivery order, with a period of performance running through February 4, 2025. This award is not set aside for any specific business categories. The primary agency receiving the...
- The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $66,600 fixed-price delivery order with economic price adjustment for COVID-19 test kits. Performance will take place in Lockhart, Florida over a period of approximately one month concluding in mid-September 2023. The contract was awarded under an unspecified government-wide acquisition contract vehicle and provides Abbott with the opportunity to supply COVID-19...
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $2,400.00, is for the delivery of COVID-19 test kits. The contract is a fixed-price delivery order with economic price adjustment and has no set-aside designation. Abbott Rapid DX North America LLC is a key supplier of medical diagnostic equipment and testing supplies to federal government agencies,...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F5A1YDelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 28, 2025, for COVID-19 test kits with a ceiling value of $2,400.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of May 7, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain, operating under the Department of Defense, is the funding federal agency for this procurement. As a key supplier of diagnostic testing products to federal healthcare agencies, Abbott Rapid DX North America LLC specializes in rapid antigen tests, point-of-care testing devices, and related medical diagnostic supplies. The company maintains an established track record with the federal government through multiple contract vehicles, including Blanket Purchase Agreements with various Veterans Integrated Service Networks. This delivery order supports the ongoing COVID-19 testing needs across federal healthcare facilities and aligns with the company's primary focus on supplying advanced medical testing technologies and diagnostic products to defense and veterans healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/28/25 |